La Jolla Pharma (LJPC)
NASDAQ:LJPC
Holding LJPC?
Track your performance easily

La Jolla Pharma (LJPC) Financial Statements

0 Followers

La Jolla Pharma Financial Overview

La Jolla Pharma's market cap is currently ―. The company's EPS TTM is $0.105; its P/E ratio is 59.18; La Jolla Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement-
Total Revenue$ 10.54M$ 10.43M$ 12.21M$ 13.31M$ 16.06M
Gross Profit$ 8.85M$ 8.26M$ 10.08M$ 10.44M$ 13.90M
EBIT$ 4.85M$ 2.40M$ 6.22M$ 500.00K$ 6.41M
EBITDA$ 5.30M$ 2.86M$ 6.68M$ 968.00K$ 6.89M
Net Income Common Stockholders$ 2.46M$ 2.00K$ 3.77M$ -2.26M$ 3.73M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 21.22M$ 27.76M$ 38.63M$ 44.56M$ 45.89M
Total Assets$ 99.37M$ 96.38M$ 101.23M$ 100.29M$ 100.01M
Total Debt$ 231.00K$ 277.00K$ 324.00K$ 1.42M$ 2.72M
Net Debt$ -20.99M$ -27.48M$ -38.31M$ -43.14M$ -43.17M
Total Liabilities$ 168.83M$ 166.87M$ 167.97M$ 168.70M$ 167.45M
Stockholders Equity$ -69.47M$ -70.49M$ -66.74M$ -68.41M$ -67.44M
Cash Flow-
Free Cash Flow$ 6.68M$ 2.52M$ 3.16M$ 757.00K$ 7.14M
Operating Cash Flow$ 6.68M$ 2.52M$ 3.16M$ 766.00K$ 7.14M
Investing Cash Flow$ 271.00K$ 0.00$ 0.00$ -9.00K$ 0.00
Financing Cash Flow$ -2.78M$ -5.02M$ -3.26M$ 120.00K$ 118.00K
Currency in USD

La Jolla Pharma Earnings and Revenue History

La Jolla Pharma Debt to Assets

La Jolla Pharma Cash Flow

La Jolla Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis